HORSHAM, Pa.--(BUSINESS WIRE)--June 28, 2006--Neose Technologies, Inc. (Nasdaq:NTEC - News) today identified Factors VIIa, VIII and IX as the three proteins that are the subject of license agreements it entered into with Novo Nordisk A/S (NYSE:NVO - News) in November 2003.
